Sort
8,912 grants matching “sars cov 2”
Innate Immunity and Viral Infection in Asthma
$1,431,641Monica Kraft · University Of Arizona · U19 · FY2023 · AI
Epidemiologic Intelligence Network (EpI-Net) to promote COVID-19 testing and prevention practices among socially vulnerable communities in Puerto Rico
$1,427,381Eida Maria Castro · Ponce School Of Medicine · R21 · FY2021 · MD
Mammalian iron-sulfur cluster biogenesis
$1,427,195Tracey A. Rouault · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2024 · HD
SBIR Phase II: Stress Pathway Inhibition To Prevent COVID-19 Infection (COVID-19)
$1,427,000Donald J Davidson · Creative Biotherapeutics Llc · · FY2022 · TIP
Antibody Neutralization Mechanisms
$1,424,677Peter D Kwong · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Immuno-Serological Assays for Monitoring COVID19 in Patients with Hematologic Malignancies
$1,423,746Rong Fan · Yale University · U01 · FY2020 · CA
A Phase 1/2a, randomized study of a Tfh-targeting genetic vaccine adjuvant designed to induce broad, durable immune responses
$1,417,453Kara W Chew · University Of California Los Angeles · U01 · FY2025 · AI
Sinonasal and Olfaction Program
$1,415,699Joshua Levy · National Institute On Deafness And Other Communication Disorders · ZIA · FY2024 · DC
ECHO Renewal for the CANOE Study Cohort
$1,414,688Tina V Hartert · Vanderbilt University Medical Center · UG3 · FY2024 · OD
CoVPN 3001 A Phase 3, Randomized, Stratified, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1273 SARS-CoV-2 Vaccine SDMC
$1,414,274Peter B. Gilbert · Fred Hutchinson Cancer Research Center · UM1 · FY2020 · AI
SARS-CoV-2 correlates of protection in a Latino-origin population
$1,413,439Carlos A Sariol · University Of Puerto Rico Med Sciences · U01 · FY2020 · CA
Alveolus as Incubator: Functional Genomic Dissection of the Host Response to SARS-CoV-2 Infection.
$1,410,500Anthony W Orvedahl · Washington University · DP2 · FY2021 · GM
Protein Expression Facility
$1,405,912Robert Petrovich · National Institute Of Environmental Health Sciences · ZIC · FY2023 · ES
Clinical Subjects and Biospecimen Core
$1,405,090Nirav Rati Bhakta · University Of California, San Francisco · U19 · FY2020 · AI
High-Throughput Molecular Profiling Core
$1,403,983Michael G Katze · Univ Of North Carolina Chapel Hill · U19 · FY2012 · AI
IP21-002, New Vaccine Surveillance Network
$1,402,123John V Williams · University Of Pittsburgh At Pittsburgh · U01 · FY2021 · IP
Emerging respiratory viruses - pathogenesis and countermeasures
$1,400,690Emmie De Wit · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
RFA-IP-22-004, Evaluating influenza, SARS-CoV-2, and other respiratory virus vaccine effectiveness in prevention of acute illness in Washington state 2022-2027
$1,400,000Karen J Wernli · Kaiser Foundation Health Plan Of Washington · U01 · FY2023 · IP
RFA-IP-22-004, Evaluating influenza, SARS-CoV-2, and other respiratory virus vaccine effectiveness in prevention of acute illness in Washington state 2022-2027
$1,400,000Karen J Wernli · Kaiser Foundation Health Plan Of Washington · U01 · FY2024 · IP
RFA-IP-22-004, Michigan-Ford Initiative to Measure Vaccine Effectiveness (MFIVE): Seasonal Influenza, COVID-19 and Respiratory Virus Vaccines
$1,400,000Emily Toth Martin · University Of Michigan At Ann Arbor · U01 · FY2023 · IP
Evaluation of Novel Technologies to Improve Clinical Management of Celiac Disease: The GLUTECH Trial
$1,400,000Benjamin Lebwohl · Columbia University Health Sciences · U01 · FY2025 · DK
RFA-IP-22-004, Component A _ Credible Effectiveness Measures of Seasonal Influenza, COVID-19 and Other Respiratory Virus Vaccines against Ambulatory Care for Acute Illness in Texas (and Component D).
$1,400,000Manjusha Gaglani · Baylor Research Institute · U01 · FY2023 · IP
Protein Structure
$1,397,273Alexander Wlodawer · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Project 1: Characterization of the Antibody Response to SARS-CoV-2 in Lung Cancer Patients
$1,396,346Florian Krammer · Icahn School Of Medicine At Mount Sinai · U54 · FY2020 · CA
Project-002
$1,393,751Leonidas A Stamatatos · Fred Hutchinson Cancer Center · U19 · FY2024 · AI